Actively Recruiting

All Genders
ID05978141

The T-cell Lymphoma Master Repository: A Prospective Databank of Patients With T-cell Lymphoma Including Clinical Data and Tumor Samples

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-05-20

1000

Participants Needed

26

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are collecting detailed information in a registry to better understand various types of mature T-cell and natural killer (NK)-cell lymphomas. This observational study aims to improve knowledge about these rare blood cancers by creating a comprehensive database that includes clinical information and tumor samples from participants. The study is sponsored by Memorial Sloan Kettering Cancer Center and focuses on multiple specific T-cell lymphoma subtypes as defined by recognized classification guidelines. Participants with confirmed mature T-cell or NK-cell lymphoma may choose to provide optional blood and nail samples for future research and biobanking. The study does not involve experimental treatments but gathers data prospectively from individuals meeting strict diagnostic criteria, including those receiving systemic therapy for certain cutaneous lymphoma types. This approach supports long-term data collection rather than testing new therapies. During the study, participants will have clinical data and tumor specimens collected and recorded. Researchers will track the number of participants contributing to the T-cell Lymphoma Master Repository over a 10-year period. The study involves ongoing follow-up to measure disease status and treatment response, with no direct intervention required. Participation helps build a resource to advance future research and understanding of these lymphomas.

CONDITIONS

Brief Title

A Registry for People With T-cell Lymphoma

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Provided written informed consent
  • Have an adequate fresh or archival tumor biopsy or plan to obtain one
  • Diagnosed with a mature T-cell or natural killer (NK)-cell lymphoma matching recognized criteria, including types such as T-cell prolymphocytic leukemia, aggressive NK-cell leukemia, adult T-cell leukemia/lymphoma, mycosis fungoides (stage IB or higher and receiving active therapy), Sézary syndrome, and others listed
  • For mycosis fungoides, primary cutaneous anaplastic large cell lymphoma, or primary cutaneous acral CD8+ T-cell lymphoma, must be receiving systemic therapy
Not Eligible

You will not qualify if you...

  • Diagnosed with mycosis fungoides, primary cutaneous anaplastic large cell lymphoma, or primary cutaneous acral CD8+ T-cell lymphoma but not receiving systemic therapy
  • Unable to provide prospective data, measure response, or complete follow-up assessments as judged by the treating physician
  • Patients already in clinical trials may still participate, and participation here does not exclude other trials or vice versa without physician judgment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 10 years

Participants with T-cell lymphoma are observed over time, including optional provision of blood and nail samples for biobanking and future research.

Visits as needed for data collection and sample provision

Trial Site Locations

Total: 26 locations

1

City of Hope Cancer Center (Data collection only)

Duarte, California, United States, 91010

Not Yet Recruiting

2

UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only)

San Diego, California, United States, 92103

Not Yet Recruiting

3

University of California San Francisco (Data collection only)

San Francisco, California, United States, 94143

Not Yet Recruiting

4

Stanford University Medical Center (Data collection only)

Stanford, California, United States, 94305-5408

Not Yet Recruiting

5

University of Colorado (Data Collection Only)

Aurora, Colorado, United States, 80045

Not Yet Recruiting

6

Yale University (Data Collection Only)

New Haven, Connecticut, United States, 06511

Not Yet Recruiting

7

University of Miami (Data Collection Only)

Miami, Florida, United States, 33136

Not Yet Recruiting

8

Moffitt Cancer Center (Data Collection Only)

Tampa, Florida, United States, 33612

Not Yet Recruiting

9

Emory University (Data Collection Only)

Atlanta, Georgia, United States, 30322

Not Yet Recruiting

10

Northwestern Medicine (Data Collection)

Chicago, Illinois, United States, 60611

Not Yet Recruiting

11

Massachusetts General Hospital (Data Collection Only)

Boston, Massachusetts, United States, 02114

Not Yet Recruiting

12

Dana Farber Cancer Institute (Data Collection Only)

Boston, Massachusetts, United States, 02115

Not Yet Recruiting

13

Mayo Clinic (Data Collection Only)

Rochester, Minnesota, United States, 55905

Not Yet Recruiting

14

Washington University (Data Collection Only)

St Louis, Missouri, United States, 63110

Not Yet Recruiting

15

University of Nebraska (Data collection only)

Omaha, Nebraska, United States, 68198-7680

Not Yet Recruiting

16

Memorial Sloan Kettering at Basking Ridge (All protocol activities)

Basking Ridge, New Jersey, United States, 07920

Actively Recruiting

17

Memorial Sloan Kettering Monmouth (All protocol activities)

Middletown, New Jersey, United States, 07748

Actively Recruiting

18

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities)

Commack, New York, United States, 11725

Actively Recruiting

19

Memorial Sloan Kettering Westchester (All protocol activities)

Harrison, New York, United States, 10604

Actively Recruiting

20

Weill Cornell Medical Center (Data Collection Only)

New York, New York, United States, 10021

Not Yet Recruiting

21

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, United States, 10065

Actively Recruiting

22

Memorial Sloan Kettering Nassau (All protocol activities)

Uniondale, New York, United States, 11553

Actively Recruiting

23

Ohio State University (Data Collection Only)

Columbus, Ohio, United States, 43210

Not Yet Recruiting

24

University of Pennsylvania (Data Collection Only)

Philadelphia, Pennsylvania, United States, 19104

Not Yet Recruiting

25

Thomas Jefferson University Hospital (Data collection only)

Philadelphia, Pennsylvania, United States, 19107

Not Yet Recruiting

26

MD Anderson Cancer Center (Data Collection Only)

Houston, Texas, United States, 77030

Not Yet Recruiting

Loading map...

Research Team

S

Steven Horwitz, MD

A

Alison Moskowitz, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Phase I Trial of Anti-CCR4 CAR T Cells for CCR4-Expressing M...

Relapsed and/or Refractory Mature T Cell Malignancy

Actively Recruiting

1 location

A Multicenter, Open-Label, First-In-Human Phase 1/2 Study to...

LGLL - Large Granular Lymphocytic Leukemia

Actively Recruiting

37 locations

A Phase 2 Study of Enasidenib in IDH2-Mutant Angioimmunoblas...

T-cell Lymphoma

Actively Recruiting

8 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here